T-cell-independent Antitumor Effects of CD40 Ligation
- 17 July 2012
- journal article
- review article
- Published by Taylor & Francis Ltd in International Reviews of Immunology
- Vol. 31 (4), 267-278
- https://doi.org/10.3109/08830185.2012.698337
Abstract
CD40 ligation has been shown to induce antitumor effects in mice and cancer patients. Most of the studies have focused on the ability of an agonistic anti-CD40 mAb to either directly kill CD40-positive tumor cells or activate T-cell immune responses. In this review the authors focus on the ability of CD40 ligation to activate antitumor effector mechanisms of the cells of innate immunity such as macrophages and NK cells.Keywords
This publication has 89 references indexed in Scilit:
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and HumansScience, 2011
- Enhanced T-cell-independent Antitumor Effect of Cyclophosphamide Combined With Anti-CD40 mAb and CpG in MiceJournal of Immunotherapy, 2011
- Biology and Clinical Applications of CD40 in Cancer TreatmentSeminars in Oncology, 2010
- Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophagesImmunology, 2010
- The role of CD40 and CD154/CD40L in dendritic cellsSeminars in Immunology, 2009
- Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40British Journal of Cancer, 2008
- Anti-CD40 agonist antibodies: Preclinical and clinical experienceUpdate on Cancer Therapeutics, 2007
- Macrophages are essential for antitumour effects against weakly immunogenic murine tumours induced by class B CpG‐oligodeoxynucleotidesImmunology, 2006
- Transferable anticancer innate immunity in spontaneous regression/complete resistance miceProceedings of the National Academy of Sciences of the United States of America, 2006
- Tumoristatic effects of anti‐CD40 mAb‐activated macrophages involve nitric oxide and tumour necrosis factor‐αImmunology, 2006